Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

EC mulls changes to Orphan Drug rules

Tweaks to EU orphan drug rules (OD) may be needed to accommodate Ebola treatment development and block industry attempts to delay generic entry says the European Commission.

European Commission

AZ not worried about giving Sanofi a potential blockbuster in swap deal

AstraZeneca says it had no worries about giving rival Sanofi a potential blockbuster drug when the two exchanged compound library molecules this month. 

Ash Stevens to make API for Takeda's new oral blood cancer drug

The US FDA has cleared Ash Stevens to make the API for Takeda's new multiple myeloma drug Ninlaro, which is the first oral proteasome inhibitor to be approved in the country.

Pfizer gets OK for $160bn Allergan acquisition

The boards of Pfizer and Allergan yesterday signed a $160bn merger that will create the world’s biggest pharmaceutical company.

API sourcing leads US Gov to label Carlsbad's Acyclovir tablets as made in Asia

US Customs and Border Protection (CBP) says the country of origin of Carlsbad Technology’s acyclovir is where the API is sourced, not the US where the tablets are made.

Strides Shasun restarts API production at fire struck plant

Strides Shasun has restarted some active pharmaceutical ingredient (API) production at a plant in Cuddalore, India after a fire last week.


Turing head Martin Shkreli buys out failing biotech

Martin Shkreli, the CEO who recently hiked the price of Turing's HIV drug, has taken over KaloBios.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...